AKBA
USDAkebia Therapeutics Inc. Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$2.100
उच्च
$2.145
कम
$2.070
मात्रा
4.47M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
563.4M
उद्योग
Drug Manufacturers - Specialty & Generic
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
4.04M
एक्सचेंज
NCM
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Akebia Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
HC Wainwright & Co. Maintains Buy on Akebia Therapeutics, Lowers Price Target to $6
HC Wainwright & Co. analyst Matthew Caufield maintains Akebia Therapeutics with a Buy and lowers the price target from $8 to $6.
BTIG Maintains Buy on Akebia Therapeutics, Lowers Price Target to $5
BTIG analyst Julian Harrison maintains Akebia Therapeutics with a Buy and lowers the price target from $10 to $5.
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced
संबंधित स्टॉक
SAZ
Saratoga Investment Corp 8.50% Notes due 2028
PTWOW
Pono Capital Two Inc. Warrants
XELA
Exela Technologies Inc.
APOS
Apollo Global Management Inc. 7.625% Fixed-Rate Resettable Junior Subordinated Notes due 2053
MLTX
MoonLake Immunotherapeutics Ordinary Shares
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।